pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4281 |
Genomic Coordinates | chr5: 176629439 - 176629500 |
Description | Homo sapiens miR-4281 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4281 | ||||||||||||||||||||||||
Sequence | 35| GGGUCCCGGGGAGGGGGG |52 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC29A2 | ||||||||||||||||||||
Synonyms | DER12, ENT2, HNP36 | ||||||||||||||||||||
Description | solute carrier family 29 member 2 | ||||||||||||||||||||
Transcript | NM_001532 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC29A2 | |||||||||||||||||||||
3'UTR of SLC29A2 (miRNA target sites are highlighted) |
>SLC29A2|NM_001532|3'UTR 1 AGTGGCCCCTCCAGGCTCTTTGGCAGCCTCTTCTCGACGTCTCCTTCCGGAGCTGAGATCCAGCCCAGGGCGAATGGCGA 81 GCTTGGCTCAGGCCTCTGCGGGGTGGAGGCCCCTGGGCCTGAGGCTGCCAGCAGCGGGCAGGAGCTGCTCTTCATCCACT 161 TGGAGTGCTGCGGGGAAGAAATCACCACCGGTCATTCTAACCCTCACCCAGGAATGGGGGTGACTCGCACAAGACCTCAT 241 GGAAAGGGTGATGACTAGGGAAAAGAGGGTGCAGGGCACGGCTGCTCCCCACCACCAGGTCTGCATTTGTTCATCATCAT 321 CAGGAGCAGAGGTGACCAGAGGGTTCAGAGTGGGAGGCGGGGCCAGCCCAGGCCAGGAGCGCCTCATCTTCCCAGGCCTC 401 AGCCACCCAGGGTAAAAGGTGCCAGGGAAGTTGTGGGCACCTGAGAGGAGGAACAGATGTGGAGGACCTGAGGGTGCTCA 481 AAGGGCCAGGCTCAGCCTCAAGCAGTGTTTTCATTGCCAACACTTACTGTACCCACTCCGCAGAGCCCAGCTGGGCCTGG 561 GCCCCAGGGCCACAGCTAGCCTGCATGTGTGTACTGCACTTTACAGTTTGCAAAGCTCTTCCATACCCACTCTCTCACCG 641 AAGCCTAATTGAGGCTCTTGGAAGGAGTCAGGCAAGGATTGTGCTTCCCCCATTATACAGGTGACAAAACTGAGTCCTGG 721 GGAAAGTGACTGGTCCGTGGTAGAGCCGGGACCCAATCCCCTCTCTCTCCTCCCTGTTGGTGCTGTTCTTCCTGCCCAAC 801 ACCTGTTTCTCTTTTCCTCAAGGGGTTTGGGGCAGGAGCCTGGGCACTTACTCCCCGTTTTTGCTGTTTCTCCTTCTGAC 881 CCTGCTCTTGGGTCTAATAACCCCATTTATTTGTAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | TZM-bl | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000311161.7 | 3UTR | ACCCAAUCCCCUCUCUCUCCUCCCUGUUGGUGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
29 hsa-miR-4281 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT218864 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 4 | ||||||||
MIRT248841 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT452803 | PACS2 | phosphofurin acidic cluster sorting protein 2 | 2 | 2 | ||||||||
MIRT462825 | BCL3 | B-cell CLL/lymphoma 3 | 2 | 2 | ||||||||
MIRT467812 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT477707 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT490047 | PRRT2 | proline rich transmembrane protein 2 | 2 | 2 | ||||||||
MIRT491813 | ZBTB7B | zinc finger and BTB domain containing 7B | 2 | 2 | ||||||||
MIRT528905 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT534124 | SNX33 | sorting nexin 33 | 2 | 2 | ||||||||
MIRT550881 | IBA57 | IBA57 homolog, iron-sulfur cluster assembly | 2 | 2 | ||||||||
MIRT551263 | PSMG1 | proteasome assembly chaperone 1 | 2 | 2 | ||||||||
MIRT551984 | UGT2B10 | UDP glucuronosyltransferase family 2 member B10 | 2 | 2 | ||||||||
MIRT608916 | NCDN | neurochondrin | 2 | 6 | ||||||||
MIRT637226 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT644445 | ALDOC | aldolase, fructose-bisphosphate C | 2 | 2 | ||||||||
MIRT657162 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT658754 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT668304 | FOSL2 | FOS like 2, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT687548 | MLEC | malectin | 2 | 2 | ||||||||
MIRT690860 | PLEKHG2 | pleckstrin homology and RhoGEF domain containing G2 | 2 | 2 | ||||||||
MIRT697063 | PSMC4 | proteasome 26S subunit, ATPase 4 | 2 | 2 | ||||||||
MIRT700860 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT705073 | C4orf29 | abhydrolase domain containing 18 | 2 | 2 | ||||||||
MIRT713930 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT715904 | MFRP | membrane frizzled-related protein | 2 | 2 | ||||||||
MIRT716060 | SFTPB | surfactant protein B | 2 | 2 | ||||||||
MIRT716729 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT723382 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|